Paediatric Mycosis Fungoides: Clinical Variants, Treatment Modalities and Response to Therapy
DOI:
https://doi.org/10.2340/actadv.v103.6557Keywords:
mycosis fungoides, folliculotropic, paediatric, cutaneous lymphoma, phototherapyAbstract
Mycosis fungoides is a rare cutaneous lymphoma in the paediatric population. The aim of this study was to examine the epidemiological, clinical, and histological characteristics, as well as the treatment modalities and response to therapy of paediatric patients with mycosis fungoides. This retrospective cohort study reviewed the records of 37 paediatric patients treated at Rambam Medical Center, Israel, between 2013 and 2021. Extracted data included epidemiology, clinical presentation, histological reports, infiltrate clonality status, treatment modalities and response to therapy. The mean follow-up period was 60 months. All patients were diagnosed with stage IA or IB disease. Folliculotropic mycosis fungoides was the most prevalent variant (49%). Most patients were treated with phototherapy (90%), with a response rate of 85%, and a complete response rate of 55% after the first course. There were no significant differences in response to phototherapy between the folliculotropic or other variants (p = 0.072). Similarly, delayed diagnosis, atopic diathesis, clonality, phototherapy type or number of treatments, were not associated with response to therapy, while protracted phototherapy was associated with prolonged remission. In conclusion, mycosis fungoides in the paediatric population is an indolent disease with a favourable prognosis and potentially prolonged response to phototherapy.
Downloads
References
Ceppi F, Pope E, Ngan B, Abla O. Primary cutaneous lymphomas in children and adolescents. Pediatr Blood Cancer 2016; 63: 1886-1894.
https://doi.org/10.1002/pbc.26076 DOI: https://doi.org/10.1002/pbc.26076
Assaf C, Gellrich S, Steinhoff M, Nashan D, Weisse F, Dippel E, et al. Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG). J Dtsch Dermatol Ges 2007; 5: 662-668.
https://doi.org/10.1111/j.1610-0387.2007.06337.x DOI: https://doi.org/10.1111/j.1610-0387.2007.06337.x
Jung JM, Lim DJ, Won CH, Chang SE, Lee MW, Lee WJ. Mycosis fungoides in children and adolescents: a systematic review. JAMA Dermatol 2021; 157: 431-438.
https://doi.org/10.1001/jamadermatol.2021.0083 DOI: https://doi.org/10.1001/jamadermatol.2021.0083
Hodak E, Amitay-Laish I, Feinmesser M, Davidovici B, David M, Zvulunov A, et al. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement. J Am Acad Dermatol 2014; 70: 993-1001.
https://doi.org/10.1016/j.jaad.2013.12.029 DOI: https://doi.org/10.1016/j.jaad.2013.12.029
Virmani P, Levin L, Myskowski PL, Flores E, Marchetti MA, Lucas AS, et al. clinical outcome and prognosis of young patients with mycosis fungoides. Pediatr Dermatol 2017; 34: 547-553.
https://doi.org/10.1111/pde.13226 DOI: https://doi.org/10.1111/pde.13226
Wu JH, Cohen BA, Sweren RJ. Mycosis fungoides in pediatric patients: clinical features, diagnostic challenges, and advances in therapeutic management. Pediatr Dermatol 2020; 37: 18-28.
https://doi.org/10.1111/pde.14026 DOI: https://doi.org/10.1111/pde.14026
Reiter O, Amitay-Laish I, Oren-Shabtai M, Feinmesser M, Ben-Amitai D, Hodak E. Paediatric mycosis fungoides - characteristics, management and outcomes with particular focus on the folliculotropic variant. J Eur Acad Dermatol Venereol 2022; 36: 671-679.
https://doi.org/10.1111/jdv.17971 DOI: https://doi.org/10.1111/jdv.17971
Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127: 2375-2390.
https://doi.org/10.1182/blood-2016-01-643569 DOI: https://doi.org/10.1182/blood-2016-01-643569
Larocca C, Kupper T, Mycosis fungoides and Sézary syndrome: an update. Hematol Ocol Clin North Am 2019; 33: 103-120.
https://doi.org/10.1016/j.hoc.2018.09.001 DOI: https://doi.org/10.1016/j.hoc.2018.09.001
Nuckols JD, Shea CR, Horenstein MG, Burchette JL, Prieto VG. Quantitation of intraepidermal T-cell subsets in formalin-fixed, paraffin-embedded tissue helps in the diagnosis of mycosis fungoides, J Cutan Pathol 1999; 26: 169-175.
https://doi.org/10.1111/j.1600-0560.1999.tb01824.x DOI: https://doi.org/10.1111/j.1600-0560.1999.tb01824.x
Boccara O, Blanche S, de Prost Y, Brousse N, Bodemer C, Fraitag S, Cutaneous hematologic disorders in children, Pediatr Blood Cancer 2012; 58: 226-232.
https://doi.org/10.1002/pbc.23103 DOI: https://doi.org/10.1002/pbc.23103
Boulos S, Vaid R, Aladily TN, Ivan DS, Talpur R, Duvic M. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients. J Am Acad Dermatol 2014; 71: 1117-1126.
https://doi.org/10.1016/j.jaad.2014.07.049 DOI: https://doi.org/10.1016/j.jaad.2014.07.049
Koh M J-A, Chong W-S. Narrow-band ultraviolet B phototherapy for mycosis fungoides in children. Clin Exp Dermatol 2014; 39: 474-478.
https://doi.org/10.1111/ced.12364 DOI: https://doi.org/10.1111/ced.12364
Brazzelli V, Bernacca C, Segal A, Barruscotti S, Bolcato V, Michelerio A, et al. Photo-photochemotherapy in juvenile-onset mycosis fungoides: a retrospective study on 9 patients. J Pediatr Hematol Oncol 2019; 41: 34-37.
https://doi.org/10.1097/MPH.0000000000001277 DOI: https://doi.org/10.1097/MPH.0000000000001277
Krutmann J. Therapeutic photoimmunology: photoimmunological mechanisms in photo(chemo)therapy. J Photochem Photobiol B 1998; 44: 159-164.
https://doi.org/10.1016/S1011-1344(98)00139-0 DOI: https://doi.org/10.1016/S1011-1344(98)00139-0
Nanda A, AlSaleh QA, Al-Ajmi H, Al-Sabah H, Elkashlan M, Al-Shemmari S, et al. Mycosis fungoides in Arab children and adolescents: a report of 36 patients from Kuwait, Pediatr Dermatol 2010; 27: 607-613.
https://doi.org/10.1111/j.1525-1470.2010.01129.x DOI: https://doi.org/10.1111/j.1525-1470.2010.01129.x
Yazganoglu KD, Topkarci Z, Buyukbabani N, Baykal C. Childhood mycosis fungoides: a report of 20 cases from Turkey. J Eur Acad Dermatol Venereol 2013; 27: 295-300.
https://doi.org/10.1111/j.1468-3083.2011.04383.x DOI: https://doi.org/10.1111/j.1468-3083.2011.04383.x
Ramsay DL, Parnes RE, Dubin N. Response of mycosis fungoides to topical chemotherapy with mechlorethamine, Arch Dermatol 1984; 120: 1585-1590.
https://doi.org/10.1001/archderm.120.12.1585 DOI: https://doi.org/10.1001/archderm.120.12.1585
Micaily B, Miyamoto C, Kantor G, Lessin S, Rook A, Brady L, et al. Radiotherapy for unilesional mycosis fungoides. Int J Radiat Oncol Biol Phys 1998; 42: 361-364.
https://doi.org/10.1016/S0360-3016(98)00218-1 DOI: https://doi.org/10.1016/S0360-3016(98)00218-1
Huen AO, Kim EJ. The role of systemic retinoids in the treatment of cutaneous T-cell lymphoma. Dermatol Clin 2015; 33: 715-729.
https://doi.org/10.1016/j.det.2015.05.007 DOI: https://doi.org/10.1016/j.det.2015.05.007
Zackheim HS, Kashani-Sabet M, McMillan A. Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients, J Am Acad Dermatol 2003; 49: 873-878.
https://doi.org/10.1016/S0190-9622(03)01591-3 DOI: https://doi.org/10.1016/S0190-9622(03)01591-3
Whittaker S, Hoppe R, HM. How I treat mycosis fungoides and Sézary syndrome. Blood 2016; 127: 3142-3153.
https://doi.org/10.1182/blood-2015-12-611830 DOI: https://doi.org/10.1182/blood-2015-12-611830
Ben-Amitai D, Michael D, Feinmesser M, Hodak E. Juvenile mycosis fungoides diagnosed before 18 years of age. Acta Derm Venereol 2003; 83: 451-456.
https://doi.org/10.1080/00015550310020530 DOI: https://doi.org/10.1080/00015550310020530
Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas, Blood 2005; 105: 3768-3785.
https://doi.org/10.1182/blood-2004-09-3502 DOI: https://doi.org/10.1182/blood-2004-09-3502
Hodak E, Amitay-Laish I. Mycosis fungoides: a great imitator. Clin Dermatol 2019; 37: 255-267.
https://doi.org/10.1016/j.clindermatol.2019.01.004 DOI: https://doi.org/10.1016/j.clindermatol.2019.01.004
Walia R, Yeung CCS. An update on molecular biology of cutaneous T cell lymphoma. Front Oncol 2019; 9: 1558.
https://doi.org/10.3389/fonc.2019.01558 DOI: https://doi.org/10.3389/fonc.2019.01558
Ponti R, Quaglino P, Novelli M, Fierro MT, Comessatti A, Peroni A, et al. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings. Br J Dermatol 2005; 153: 565-573.
https://doi.org/10.1111/j.1365-2133.2005.06649.x DOI: https://doi.org/10.1111/j.1365-2133.2005.06649.x
Travaglino A, Varricchio S, Pace M, Russo D, Picardi M, Baldo A. Borrelia burgdorferi in primary cutaneous lymphomas: a systematic review and meta-analysis. J Dtsch Dermatol Ges 2020; 18: 1379-1384.
https://doi.org/10.1111/ddg.14289 DOI: https://doi.org/10.1111/ddg.14289
Brunner PM, Guttman-Yassky E, Leung DYM. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. J Allergy Clin Immunol 2017; 139: S65-S76.
https://doi.org/10.1016/j.jaci.2017.01.011 DOI: https://doi.org/10.1016/j.jaci.2017.01.011
Zhou H, Luo ZD, Tang XH, Han JD, Gao Q. Folliculotropic mycosis fungoides associated with atopic dermatitis. Australas J Dermatol 2018; 59: e143-e145.
https://doi.org/10.1111/ajd.12607 DOI: https://doi.org/10.1111/ajd.12607
Olsen EA, Hodak E, Anderson T, Carter JB, Henderson M, Cooper K, et al. Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: a consensus statement of the United States Cutaneous Lymphoma Consortium. J Am Acad Dermatol 2016; 74: 27-58.
https://doi.org/10.1016/j.jaad.2015.09.033 DOI: https://doi.org/10.1016/j.jaad.2015.09.033
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Orna Mirmovich Morvay, Michal Ramon , Ziad Khamaysi, Emily Avitan-Hersh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
